Melatonin-mediated calcineurin inactivation attenuates amyloid beta-induced apoptosis
Alzheimer’s disease (AD) is the most common age-related progressive neurodegenerative disorder. The accumulation of amyloid beta-peptide is a neuropathological marker of AD. While melatonin is recognized to have protective effects on aging and neurodegenerative disorders, the therapeutic effect of m...
Príomhchruthaitheoirí: | , , , , |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Elsevier
2024-06-01
|
Sraith: | IBRO Neuroscience Reports |
Ábhair: | |
Rochtain ar líne: | http://www.sciencedirect.com/science/article/pii/S2667242124000174 |